Kintegral Advisory’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,782
Closed -$252K 308
2022
Q3
$252K Hold
10,782
0.04% 251
2022
Q2
$364K Buy
10,782
+228
+2% +$7.99K 0.05% 241
2022
Q1
$369K Buy
10,554
+236
+2% +$8.07K 0.04% 252
2021
Q4
$314K Hold
10,318
0.03% 255
2021
Q3
$338K Hold
10,318
0.04% 253
2021
Q2
$312K Buy
+10,318
New +$340K 0.04% 259

Other funds holding OGN

Kintegral Advisory's OGN Position: Q4 2022 in Review

Kintegral Advisory sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 10,782 shares — an estimated $252K sold.

Kintegral Advisory first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $369K in Q1 2022. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Kintegral Advisory reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Kintegral Advisory sold 10,782 Organon & Co shares in Q4 2022, an estimated $252K.
  • Kintegral Advisory first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Kintegral Advisory's Organon & Co position peaked at $369K in Q1 2022.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Kintegral Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.